California one step closer to e-tracking
This article was originally published in The Tan Sheet
Executive Summary
The California Senate Safety Committee moves a bill that would implement a statewide, industry-funded electronic tracking system to monitor and block illegal sales of OTC medicines that contain the methamphetamine precursor pseudoephedrine. The Consumer Healthcare Products Association lauds the committee for passing AB 1455 "to fight domestic methamphetamine production while maintaining consumer access to important cold and allergy medications," according to a June 22 release. If the bill is enacted, California would join 11 other states that passed legislation to implement, or have already implemented, electronic tracking of OTC products with PSE (1"The Tan Sheet" June 21, 2010). Oregon and Mississippi made PSE containing products Rx only
You may also be interested in...
Louisiana kicks off PSE e-tracking
Louisiana implements the National Precursor Log Exchange June 15 to monitor purchases of OTC products containing pseudoephedrine. Industry bears the cost of deploying and supporting NPLEx through the Consumer Healthcare Products Association, which advocates for electronic tracking of methamphetamine precursors over prescription-only status (1"The Tan Sheet" March 29, 2010, In Brief). Louisiana Gov. Bobby Jindal called NPLEx "a critical tool to help crack down on the sale of drugs that are used to produce meth." Kentucky and Illinois also fully implemented NPLEx. Alabama, Florida, Iowa, Kansas, Missouri, South Carolina and Washington State passed legislation to adopt the NPLEx system, but have yet to implement it, according to CHPA. Oklahoma and Arkansas use separate e-tracking systems. Oregon and Mississippi shifted PSE products to Rx-only availability
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.